Skip to content

Author

Hasibullah Aminpoor

We have 8 of 79 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment

Background Two-drug antiretroviral regimens are increasingly explored to simplify HIV-1 treatment while maintaining durable viral suppression. Doravirine combined with Islatravir (DOR/ISL) represents a novel non-integrase strand transfer inhibitor (non-INSTI) regimen. However, comprehensive synthesized evidence remains...

M. Azam, M. Azam, Muhammad Arif Khan et al. · 0 citations
Open access Sep 2026

Temporal Trends and Disparities in Type 2 Diabetes Mellitus and Congestive Heart Failure Mortality in the United States From 1999–2020: A CDC WONDER Analysis

Type 2 Diabetes Mellitus (T2DM) is a growing health burden globally, and its concurrence with Congestive Heart Failure (CHF) significantly increases morbidity and mortality. However, long‐term mortality trends remain underexplored. This study aims to assess temporal trends in mortality from comorbid T2DM and CHF in the...

Syeda Sameen Afzal, Ittiqa Khatri, Mariam Bahzad et al. · 0 citations
Review Open access Oct 2026

Comparative Effectiveness of Intravenous Tenecteplase versus Alteplase in Posterior Circulation Ischemic Stroke: A Systematic Review and Meta‐Analysis

ABSTRACT Background Posterior circulation ischemic stroke (PCIS) is associated with substantial morbidity and mortality, and the optimal intravenous thrombolytic strategy in this subgroup remains unclear. Methods We searched databases for studies comparing intravenous tenecteplase with alteplase in adults with PCIS. Th...

Shaheer Bin Shafiq, A. Uddin, Muhammad Hussain et al. · 0 citations
Open access Sep 2026

National mortality trends due to OSA and respiratory failure in U.S adults from 1999–2023

Obstructive sleep apnea (OSA) and respiratory failure (RF) represent increasing clinical and public health challenges in the United States, yet national trends in mortality remain underexplored. This study evaluates trends in mortality associated with OSA and RF to highlight targeted prevention and management across de...

M. Saghir, Eshal Saghir, Nida Shoaib et al. · 0 citations
Open access Oct 2026

Temporal Trends and Socio-Demographic Disparities in Substance-Related Conditions and Coronary Artery Disease Mortality in U.S adults, 1999–2020

Coronary artery disease (CAD) is one of the major causes of death in the United States, whereas substance related conditions (SRC) are increasingly on the rise in the country. There is a paucity of information on national trends of CAD mortality over time with coexisting substance related conditions (SRC)....

M. Mustafa, Saifullah Khan, M. Saleem et al. · 0 citations
Open access Oct 2026

Trends in mortality involving chronic obstructive pulmonary disease and obesity in the United States, 1999–2023

Chronic obstructive pulmonary disease (COPD) and obesity are major US public health conditions that frequently coexist. Despite adverse respiratory and cardiometabolic effects of obesity, an apparent “obesity paradox,” whereby obesity has been associated with lower mortality in some patients with COPD, has been describ...

AM Khan, Syed Azfar Hussain, Z. Ahmad et al. · 0 citations
Meta-analysis Open access Sep 2026

Safety of Sabin-derived inactivated poliovirus vaccine in adult booster recipients: a systematic review and meta-analysis

Overall, adverse events were mild, transient, and comparable across vaccines and most included trials reported no serious adverse events (SAEs), indicating a favorable safety profile.

Muhammad Hussain, Muhammad Hassan, Abdul Hannan et al. · 0 citations
Review Sep 2026

Clinical Outcomes of Conduction System versus Right Ventricular Pacing after TAVR: A Systematic Review and Meta-Analysis.

The potential clinical relevance of CSP when a high ventricular pacing burden is anticipated remains plausible but was not directly demonstrated by the available data; adequately powered randomized trials are required before routine adoption.

R. Shakeel, A. Uddin, D. Ladhani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.